دورية أكاديمية

Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale.

التفاصيل البيبلوغرافية
العنوان: Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale.
المؤلفون: Schoen, S. P., Boscheri, A., Lange, S. A., Braun, M. U., Fuhrmann, J., Kappert, U., Strasser, A. H.
المصدر: Heart; Jul2008, Vol. 94 Issue 7, p844-847, 4p, 1 Color Photograph, 1 Black and White Photograph, 1 Chart, 1 Graph
مصطلحات موضوعية: AORTIC valve insufficiency, HEART, DIAGNOSTIC ultrasonic imaging, CARDIAC imaging, AORTIC valve
مستخلص: Background: In recent years percutaneous, transcatheter closure of atrial septal defects (ASD) or patent foramen ovale (PFO) was introduced into clinical practice. Objective: To investigate the functional effects on heart valves caused by an interatrial closure device. Methods and results: Between 2001 and 2006, 240 consecutive patients underwent percutaneous closure of an ASO or a PFO. Heart valve functions were defined by transoesophageal echocardiography before implantation and 3, 6 and 12 months after defect closure. A successful implantation procedure was performed in 98% of patients. Sufficient closure without residual shunt was achieved in 89% of patients with ASO and in 92% of patients with PFO. An overall major complication rate of 0.8% was apparent during the observation time (mean (SD) 27 (15) months). Long-term follow-up disclosed newly developed or worsened aortic valve regurgitation (AR) in 9% of patients with ASD and in 10% of patients with PFO. A potential cause for developing AR may be overgrowth of the device by tissue, leading to changes in interatrial septal geometry and traction on the root of the non-coronary aortic cusp. Conclusion: AR occurred in 9% of patients with closed ASD and in 10% of patients with closed PFO. Indication for closure should consider this potential complication despite an otherwise safe interventional procedure. [ABSTRACT FROM AUTHOR]
Copyright of Heart is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:13556037
DOI:10.1136/hrt.2007.132662